Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation

AIMS: Therapeutic drug monitoring (TDM) can optimize the efficacy of infliximab (IFX) in patients with inflammatory bowel disease (IBD). Because of the delay between blood samples taken at trough and availability of results, dose adjustments can only be carried out at the next infusion, typically 8 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Berends, Sophie E., D'Haens, Geert R. A. M., Schaap, Tiny, de Vries, Annick, Rispens, Theo, Bloem, Karien, Mathôt, Ron A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595298/
https://www.ncbi.nlm.nih.gov/pubmed/30927375
http://dx.doi.org/10.1111/bcp.13939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595298/
https://www.ncbi.nlm.nih.gov/pubmed/30927375
http://dx.doi.org/10.1111/bcp.13939

Ejemplares similares